Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

In vivo distribution of 5-Fluorouracil after peritumoral implantation using a biodegradable micro-device in tumor-bearing mice.

Zheng N, Zhou M, Lu W.

Eur J Drug Metab Pharmacokinet. 2013 Sep;38(3):183-90. doi: 10.1007/s13318-012-0111-z. Epub 2012 Nov 22.

PMID:
23179563
[PubMed - indexed for MEDLINE]
2.

Biodegradable three-dimension micro-device delivering 5-fluorouracil in tumor bearing mice.

Ren X, Zheng N, Gao Y, Chen T, Lu W.

Drug Deliv. 2012 Jan;19(1):36-44. doi: 10.3109/10717544.2011.635720.

PMID:
22211757
[PubMed - indexed for MEDLINE]
3.

5-Fluorouracil delivery from a novel three-dimensional micro-device: in vitro and in vivo evaluation.

Zheng N, Zhou M, Du C, Wang S, Lu W.

Arch Pharm Res. 2013 Dec;36(12):1487-93. doi: 10.1007/s12272-013-0168-5. Epub 2013 Jun 18.

PMID:
23775471
[PubMed - indexed for MEDLINE]
4.

Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors.

Sun W, Chen Y, Yuan W.

Int J Nanomedicine. 2013;8:1499-506. doi: 10.2147/IJN.S41462. Epub 2013 Apr 18.

PMID:
23626465
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.

Hao X, Cheng G, Zou M, Sun J, Cui F.

Pharmazie. 2004 Sep;59(9):709-12.

PMID:
15497754
[PubMed - indexed for MEDLINE]
6.

PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.

Li X, Xu Y, Chen G, Wei P, Ping Q.

Drug Dev Ind Pharm. 2008 Jan;34(1):107-15. doi: 10.1080/03639040701484593 .

PMID:
18214762
[PubMed - indexed for MEDLINE]
7.

Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts.

Smith JP, Kanekal S, Patawaran MB, Chen JY, Jones RE, Orenberg EK, Yu NY.

Cancer Chemother Pharmacol. 1999;44(4):267-74.

PMID:
10447573
[PubMed - indexed for MEDLINE]
8.

In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles.

Yan C, Gu J, Guo Y, Chen D.

Yakugaku Zasshi. 2010 Jun;130(6):801-4.

PMID:
20519858
[PubMed - indexed for MEDLINE]
Free Article
9.

Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.

Yadav AK, Agarwal A, Rai G, Mishra P, Jain S, Mishra AK, Agrawal H, Agrawal GP.

Drug Deliv. 2010 Nov;17(8):561-72. doi: 10.3109/10717544.2010.500635.

PMID:
20738221
[PubMed - indexed for MEDLINE]
10.

[Pharmacokinetics and distribution of 5-Fu magnetic albumin deuto-microsphere in normal and tumor-bearing mice].

Xu R, Shi SJ, Zhou SC, Zheng JW, Chen H, Zou SQ, Zeng FD.

Yao Xue Xue Bao. 2007 Jan;42(1):66-70. Chinese.

PMID:
17520810
[PubMed - indexed for MEDLINE]
11.

5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.

Sastre RL, Olmo R, Teijón C, Muñíz E, Teijón JM, Blanco MD.

Int J Pharm. 2007 Jun 29;338(1-2):180-90. Epub 2007 Feb 9.

PMID:
17336474
[PubMed - indexed for MEDLINE]
12.

Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.

Li S, Wang A, Jiang W, Guan Z.

BMC Cancer. 2008 Apr 15;8:103. doi: 10.1186/1471-2407-8-103.

PMID:
18412945
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice.

Jin Y, Li J, Rong LF, Lü XW, Huang Y, Xu SY.

Acta Pharmacol Sin. 2005 Feb;26(2):250-6.

PMID:
15663907
[PubMed - indexed for MEDLINE]
Free Article
14.

Selective delivery of 5-fluorouracil (5-FU) to i.p. tissues using 5-FU microspheres in rats.

Hagiwara A, Sakakura C, Tsujimoto H, Imanishi T, Ohgaki M, Yamasaki J, Sawai K, Takahashi T, Fujita T, Yamamoto A, Muranishi S, Ikada Y.

Anticancer Drugs. 1997 Feb;8(2):182-8.

PMID:
9073314
[PubMed - indexed for MEDLINE]
15.

Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites.

Wang GP, Guan YS, Jin XR, Jiang SS, Lu ZJ, Wu Y, Li Y, Li M, Luo F.

J Gastroenterol Hepatol. 2010 May;25(5):985-90. doi: 10.1111/j.1440-1746.2009.06155.x.

PMID:
20546454
[PubMed - indexed for MEDLINE]
16.

Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.

Menei P, Boisdron-Celle M, Croué A, Guy G, Benoit JP.

Neurosurgery. 1996 Jul;39(1):117-23; discussion 123-4.

PMID:
8805147
[PubMed - indexed for MEDLINE]
17.

Preparation and passive target of 5-fluorouracil solid lipid nanoparticles.

Du B, Yan Y, Li Y, Wang S, Zhang Z.

Pharm Dev Technol. 2010 Jul-Aug;15(4):346-53. doi: 10.3109/10837450903246390.

PMID:
19769532
[PubMed - indexed for MEDLINE]
18.

Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in mice.

Cheng M, Liu Z, Wan T, He B, Zha B, Han J, Chen H, Yang F, Li Q, Wang W, Xu H, Ye T.

Cancer Biol Ther. 2012 Dec;13(14):1407-16. doi: 10.4161/cbt.22001. Epub 2012 Sep 6.

PMID:
22954702
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.

Zhang C, Li G, Wang Y, Cui F, Zhang J, Huang Q.

Int J Pharm. 2012 Oct 15;436(1-2):272-81. doi: 10.1016/j.ijpharm.2012.06.022. Epub 2012 Jun 18. Erratum in: Int J Pharm. 2012 Dec 15;439(1-2):360.

PMID:
22721846
[PubMed - indexed for MEDLINE]
20.

Pharmacokinetic study and effectiveness evaluation of slow-release PLGA-5-fluorouracil microsphere.

Li J, Pu Y, Wang S, Ding M, Chen D, Zhu M.

Cancer Chemother Pharmacol. 2013 Feb;71(2):351-9. doi: 10.1007/s00280-012-2016-6. Epub 2012 Nov 8.

PMID:
23135527
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk